Dean and Professor
Loma Linda University School of Pharmacy , California
Michael D. Hogue is Dean and Professor of Loma Linda University School of Pharmacy, Loma Linda, California, and also is a professor of preventive medicine at LLU's School of Medicine. He is the 165th President of the American Pharmacists Association. Dr. Hogue has many experiences in pharmacy practice, including owning an independent community pharmacy and home infusion company, working in a chain community pharmacy, and later as an ambulatory care pharmacist in family practice medicine.
Dr. Hogue was on the staff development team and an original national faculty member for APhA’s Pharmacy-Based Immunization Delivery national certificate program for pharmacists, which an estimated 400,000 pharmacists, student pharmacists and pharmacy technicians have completed since its inception in 1996. He has conducted several studies in the area of vaccine implementation through pharmacies, written dozens of manuscripts and monographs related to vaccines and vaccine-preventable diseases, and speaks frequently around the globe on the subject. Dr. Hogue was the first pharmacist in the state of Alabama to administer vaccines in his pharmacy practice in 1997, and because of his longstanding vaccination efforts in that state was inducted into the Alabama Healthcare Hall of Fame in 2018. Currently, Hogue serves as the APhA Liaison Representative to the Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practices (ACIP), and also serves on the CDC's COVID-19 Vaccine and Adult RSV Vaccine Workgroups. He is also a board member of the California Immunization Coalition.
Dr. Hogue is a Fellow of APhA, the National Academies of Practice, and the International Pharmaceutical Federation (FIP). His wife, Heather, is also a pharmacist. A native of Southern Illinois, Dr. Hogue practiced for the majority of his career in Alabama prior to moving to Southern California to become Loma Linda's Dean of pharmacy.
Friday, March 24, 2023
10:30 AM – 12:30 PM
Disclosure(s): Merck Vaccine: Advisory Committee/Board Member (Terminated, June 1, 2022); Sanofi: Advisory Committee/Board Member (Terminated, May 31, 2022)
Sunday, March 26, 2023
10:00 AM – 11:00 AM
Disclosure(s): Merck Vaccine: Advisory Committee/Board Member (Terminated, June 1, 2022); Sanofi: Advisory Committee/Board Member (Terminated, May 31, 2022)